Foyouzi Reproductive Genetic Medical Corporation — An Honest Editorial Review
Among fertility clinics in California, very few are led by a physician who holds board certification in both reproductive endocrinology and medical genetics. Foyouzi Reproductive Genetic Medical Corporation — the corporate entity behind Southern California Fertility Center (SCFC) — is Dr. Nastaran ("Nam") Foyouzi-Yousefi's La Jolla practice, a boutique fertility center that pairs IVF with an in-house reproductive genetics program. The office sits on Villa La Jolla Drive, a short drive from UC San Diego and Scripps.
Dr. Foyouzi is the founder and medical director. She is board-certified in Obstetrics & Gynecology by the American Board of Obstetrics and Gynecology (ABOG) and in Medical Genetics and Genomics by the American Board of Medical Genetics and Genomics (ABMGG), and uses the post-nominals FACOG and FACMG.
Training and Credentials
Dr. Foyouzi completed an internship in Obstetrics and Gynecology at Yale University, her OB-GYN residency at Washington University in St. Louis, her fellowship in Reproductive Endocrinology & Infertility at the University of California, San Francisco (UCSF), and a second fellowship in Medical Genetics at the University of California, Los Angeles (UCLA). That UCSF-plus-UCLA combination — REI plus medical genetics — is unusual among practicing REIs in the United States.
She has published peer-reviewed work on ovarian theca-interstitial cell biology, oxidative stress, pituitary physiology in pregnancy, GnRH signaling at the maternal-fetal interface, and more recently on the clinical and ethical considerations of polygenic risk scores in embryo selection (Genetics in Medicine, 2024). Browse her PubMed publications.
Services and Specialties
Services at Foyouzi Reproductive Genetic Medical Corporation / SCFC include:
- In Vitro Fertilization (IVF), including frozen embryo transfer
- Intrauterine Insemination (IUI) and ovulation induction
- egg freezing and fertility preservation, including for patients with inherited cancer syndromes
- donor egg IVF and third-party reproduction
- Preimplantation genetic testing (PGT-A, PGT-M, PGT-SR) and HLA typing
- Reproductive genetics consultation for recurrent pregnancy loss and inherited disease
- LGBTQ+ family-building and gender-affirming fertility preservation
Success Rates and Lab Quality
U.S. IVF programs that perform cycles for the SART registry publish outcomes on the SART Clinic Summary Report and, in aggregate, on the CDC ART Success Rates report. Check the current SART report for this clinic directly before your consult; a boutique program's published numbers can look very different from a high-volume academic center because of cycle mix and patient selection. Our how to read IVF success rates guide walks through how to compare within your own age band and diagnosis.
Patient Experience
Dr. Foyouzi's Google rating is 5.0 across 13 reviews — a small sample, but consistent. Recurring themes in public patient commentary emphasize unusually thorough genetic counseling, direct physician communication (rather than hand-off to a nurse), and attention to patients with complex histories — recurrent pregnancy loss, prior failed cycles elsewhere, and single-gene disease carriers pursuing PGT-M. As with any smaller practice, scheduling flexibility and wait time between cycles are worth asking about at the consult.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), a history of recurrent pregnancy loss, or a known inherited condition you're hoping to screen against, a board-certified reproductive endocrinologist — ideally one with genetics training — is the right next step.
Insurance and Cost in California
California's SB 729 (signed in 2024, with coverage phased in) significantly expands state-regulated large-group insurance coverage for the diagnosis and treatment of infertility, including IVF. Self-funded (ERISA) employer plans remain exempt. Verify benefits and carrier compliance before your first consult, especially if you're early in the rollout window. See our fertility insurance mandates by state guide and IVF cost by state breakdown for what to expect on out-of-pocket pricing in California.
Location and Contact
Address: 8950 Villa La Jolla Dr., Suite B225, La Jolla, CA 92037 Phone: (858) 272-2900 Website: scfertilitycenter.com
Frequently Asked Questions
Is Dr. Foyouzi accepting new patients? Availability changes throughout the year. Contact the office at (858) 272-2900 to confirm.
What makes this practice different from a larger San Diego IVF center? Dr. Foyouzi is board-certified in both REI (ABOG subspecialty) and Medical Genetics and Genomics (ABMGG), which is uncommon. Patients with recurrent pregnancy loss, single-gene disorders, or a family history of inherited cancer often value having PGT and genetic counseling led by the same physician who is directing the IVF cycle.
Does the clinic offer fertility preservation before cancer treatment? Yes — fertility preservation, including for patients with inherited cancer syndromes, is listed among the practice's core services. Timelines for cancer patients are typically short, so call the office directly to discuss urgent scheduling.
Editorial note: Independently written by the Fertlo editorial team; not sponsored. See our editorial policy.